Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00506116 · ClinicalTrials.gov registry record · Phase 3
Promoting Effective Recovery From Labor Urinary Incontinence (PERL)
A Phase 3 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 3
- Development phase
- 140
- Enrollment target
NCT00506116: Completed Phase 3 study, sponsored by University of Michigan.
NCT00506116 is a Phase 3 study that has completed, run by University of Michigan. The registered enrollment target is 140 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00506116, a Phase 3 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 140 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether pushing during labor that is controlled by the woman results in less birth-related injury and less postpartum urinary incontinence (UI).
Interventions
- BEHAVIORAL Videotape, routine care, PME instruction
- BEHAVIORAL PME practice and record keeping (in diaries)
- BEHAVIORAL Non-directed or directed,spontaneous or sustained pushing
- PROCEDURE Data collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 1996-07 |
| Est. Completion | 2006-12 |
| Phase | Phase 3 |
What the finished NCT00506116 record still lists
NCT00506116 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 4 interventions - of which Videotape, routine care, PME instruction is the first listed.
NCT00506116 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00506116 about?
NCT00506116 is a clinical study titled "Promoting Effective Recovery From Labor Urinary Incontinence (PERL)". The purpose of this study is to determine whether pushing during labor that is controlled by the woman results in less birth-related injury and less postpartum urinary incontinence (UI).
What is the current status of trial NCT00506116?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 140 participants. The study started on 1996-07. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00506116?
The interventions under investigation include: Videotape, routine care, PME instruction (BEHAVIORAL), PME practice and record keeping (in diaries) (BEHAVIORAL), Non-directed or directed,spontaneous or sustained pushing (BEHAVIORAL), Data collection (PROCEDURE).
Who is sponsoring clinical trial NCT00506116?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00506116's enrollment target sits among peer trials
140 1565th of 2000 higher than 424 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia